A Randomized Pilot Trial of a Steroid-Free Immunosuppressant Regimen in Pediatric Liver Transplantation

Trial Profile

A Randomized Pilot Trial of a Steroid-Free Immunosuppressant Regimen in Pediatric Liver Transplantation

Discontinued
Phase of Trial: Phase III

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Daclizumab (Primary) ; Hydrocortisone (Primary) ; Methylprednisolone (Primary) ; Prednisolone (Primary) ; Corticosteroids; Immunosuppressants
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Acronyms SFPT-OL
  • Most Recent Events

    • 21 Mar 2015 United Kingdom Clinical Research Network reports accrual to date changed from 66% to 70%.
    • 08 Apr 2014 Last checked against ISRCTN: Current Controlled Trials.
    • 22 Oct 2013 Status changed from recruiting to discontinued as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top